Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

Periodontitis, Chronic Clinical Trial

Official title:
Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction Immobilised on a Biodegradable Carrier

Status Completed

Clinical Trial Summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Clinical Trial Description

The bone defect will be filled with a porous membrane based on bone collagen measuring 5x5 mm or more with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04446897
Study type	Interventional
Source	Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 3, 2020
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06426069` - Assessment of Masticatory Performance in Periodontitis
Recruiting	`NCT06058923` - MIST Versus M-MIST for the Treatment of Intrabony Defects	N/A
Terminated	`NCT03262701` - Adjunctive Hydrogen Peroxide for Periodontal Therapy	Phase 4
Completed	`NCT03264118` - Effects of Antimicrobial Photodynamic Therapy on Regeneration of Class II Furcation Lesions	N/A